CR11665A - Farmacoforos duales-antagonistas muscarinicos de pde4 - Google Patents
Farmacoforos duales-antagonistas muscarinicos de pde4Info
- Publication number
- CR11665A CR11665A CR11665A CR11665A CR11665A CR 11665 A CR11665 A CR 11665A CR 11665 A CR11665 A CR 11665A CR 11665 A CR11665 A CR 11665A CR 11665 A CR11665 A CR 11665A
- Authority
- CR
- Costa Rica
- Prior art keywords
- pde4
- pharmacophoris
- muscarinic antagonists
- receptors
- machrs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a nuevos compuestos de la fórmula (I) y a sus sales farmacéuticamente aceptables, a composiciones farmacéuticas y a su uso como cromóforos duales que tienen actividad inhibitoria contra receptores de PDE4 y receptores muscarínicos de acetilcolina (maChRs), siendo así de utilidad para tratar enfermedades respiratorias.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2656308P | 2008-02-06 | 2008-02-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11665A true CR11665A (es) | 2011-01-11 |
Family
ID=40935342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11665A CR11665A (es) | 2008-02-06 | 2010-09-01 | Farmacoforos duales-antagonistas muscarinicos de pde4 |
Country Status (19)
Country | Link |
---|---|
US (1) | US8084449B2 (es) |
EP (1) | EP2259681A4 (es) |
JP (1) | JP2011511082A (es) |
KR (1) | KR20100113155A (es) |
CN (1) | CN101990401A (es) |
AR (1) | AR070562A1 (es) |
AU (1) | AU2009212408A1 (es) |
BR (1) | BRPI0908008A2 (es) |
CA (1) | CA2714352A1 (es) |
CL (1) | CL2009000250A1 (es) |
CR (1) | CR11665A (es) |
DO (1) | DOP2010000235A (es) |
EA (1) | EA201070916A1 (es) |
IL (1) | IL207352A0 (es) |
MX (1) | MX2010008690A (es) |
PE (1) | PE20091552A1 (es) |
TW (1) | TW201000476A (es) |
UY (1) | UY31637A1 (es) |
WO (1) | WO2009100166A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103119034B (zh) | 2010-04-16 | 2016-08-03 | 拜耳知识产权有限责任公司 | 作为害虫防治剂的杂环化合物 |
AR081377A1 (es) | 2010-05-10 | 2012-08-29 | Gilead Sciences Inc | Compuestos de pirazolopiridina bifuncionales |
ES2626601T3 (es) | 2010-06-28 | 2017-07-25 | Bayer Intellectual Property Gmbh | Compuestos heterocíclicos como pesticidas |
US9763924B2 (en) * | 2014-06-05 | 2017-09-19 | Chiesi Farmaceutici S.P.A. | Aminoester derivatives |
AU2015346374A1 (en) | 2014-11-11 | 2017-04-27 | Johnson & Johnson Consumer Inc. | Amino acid derivatives and their uses |
US9321744B1 (en) | 2015-06-26 | 2016-04-26 | Industrial Technology Research Institute | Method for preparing 2,5-furan dicarboxylic acid |
WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3925388A (en) * | 1971-08-05 | 1975-12-09 | Squibb & Sons Inc | 4-Piperazino-{8 3,4-b{9 pyridine-5-carboxylic acids and esters |
BE787249A (fr) * | 1971-08-05 | 1973-02-05 | Squibb & Sons Inc | Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation |
US3856799A (en) * | 1971-08-05 | 1974-12-24 | Squibb & Sons Inc | Intermediates for production of amino derivatives of pyrazolopyridine carboxylic acids and esters |
US3833594A (en) * | 1971-08-05 | 1974-09-03 | Squibb & Sons Inc | Amino derivatives of pyrazolopyridine carboxylic acids and esters |
CA1003419A (en) | 1971-11-23 | 1977-01-11 | Theodor Denzel | Process for the production of pyrazolo (3,4-b) pyridines |
US3979399A (en) * | 1972-11-15 | 1976-09-07 | E. R. Squibb & Sons, Inc. | Amino derivatives of pyrazolopyridine carboxamides |
US3840546A (en) * | 1972-11-15 | 1974-10-08 | Squibb & Sons Inc | Amino derivatives of pyrazolopyridine carboxamides |
US4364948A (en) | 1981-09-28 | 1982-12-21 | Ici Americas Inc. | Pyrazolo[3,4-b]pyridine compounds |
US6326379B1 (en) | 1998-09-16 | 2001-12-04 | Bristol-Myers Squibb Co. | Fused pyridine inhibitors of cGMP phosphodiesterase |
US6670364B2 (en) | 2001-01-31 | 2003-12-30 | Telik, Inc. | Antagonists of MCP-1 function and methods of use thereof |
TWI236474B (en) | 2001-04-03 | 2005-07-21 | Telik Inc | Antagonists of MCP-1 function and methods of use thereof |
CA2462441A1 (en) * | 2001-10-18 | 2003-04-24 | Pier F. Cirillo | 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
EP1499598A1 (en) | 2002-04-18 | 2005-01-26 | Ucb, S.A. | Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
TW200410951A (en) | 2002-08-06 | 2004-07-01 | Glaxo Group Ltd | M3 muscarinic acetylcholine receptor antagonists |
GB0230045D0 (en) | 2002-12-23 | 2003-01-29 | Glaxo Group Ltd | Compounds |
ES2331119T3 (es) * | 2002-09-16 | 2009-12-22 | Glaxo Group Limited | Compuestos de pirazolo(3,4-b)piridina, y su uso como inhibidores de fosfodiesterasa. |
WO2004091482A2 (en) | 2003-04-07 | 2004-10-28 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
AR048573A1 (es) | 2003-07-17 | 2006-05-10 | Glaxo Group Ltd | Compuesto de 8-azoniabiciclo[3.2.1]octano sustituido en la posicion 3, composicion farmceutica que lo comprende y su uso para preparar esta ultima |
PE20050250A1 (es) | 2003-07-17 | 2005-04-08 | Glaxo Group Ltd | Antagonistas de los receptores muscarinicos de la acetilcolina |
UY28417A1 (es) | 2003-07-17 | 2005-02-28 | Glaxo Group Ltd | Antagonistas de los receptores muscarinicos de la acetilcolina |
AP2007004239A0 (en) | 2003-10-14 | 2007-12-31 | Glaxo Group Ltd | Muscarinic acetycholine receptor antagonists |
EP1677796A4 (en) | 2003-10-17 | 2006-12-27 | Glaxo Group Ltd | MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS |
PE20050489A1 (es) | 2003-11-04 | 2005-09-02 | Glaxo Group Ltd | Antagonistas de receptores de acetilcolina muscarinicos |
AR046783A1 (es) | 2003-12-03 | 2005-12-21 | Glaxo Group Ltd | Compuesto de sal ciclica de amonio cuaternario composicion farmaceutica que lo comprende y su uso para preparar esta ultima |
UY28645A1 (es) | 2003-12-03 | 2005-06-30 | Glaxo Group Ltd | Nuevos antagonistas del receptor muscarinico m3 de acetilcolina |
US20070111995A1 (en) * | 2003-12-19 | 2007-05-17 | Allen David G | Pyrazolo [3,4-B] pyridine Compounds and Their Use as Phosphodiesterase Inhibitors |
TW200534855A (en) | 2004-01-13 | 2005-11-01 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
WO2005087236A1 (en) | 2004-03-11 | 2005-09-22 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
JP2007530451A (ja) | 2004-03-11 | 2007-11-01 | グラクソ グループ リミテッド | 新規m3ムスカリン性アセチルコリン受容体アンタゴニスト |
BRPI0508843A (pt) | 2004-03-16 | 2007-08-28 | Glaxo Group Ltd | composto ou sal do mesmo, método para preparar um composto ou um sal do mesmo, método de tratamento e/ou profilaxia de doença, e, composição farmacêutica |
GB0405937D0 (en) * | 2004-03-16 | 2004-04-21 | Glaxo Group Ltd | Compounds |
GB0405933D0 (en) | 2004-03-16 | 2004-04-21 | Glaxo Group Ltd | Compounds |
JP2007529513A (ja) | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | M3ムスカリン性アセチルコリン受容体アンタゴニスト |
JP2007529514A (ja) | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | M3ムスカリン性アセチルコリン受容体アンタゴニスト |
JP2007529511A (ja) | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | M3ムスカリン性アセチルコリン受容体アンタゴニスト |
JP2007529512A (ja) | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | ムスカリン性アセチルコリン受容体アンタゴニスト |
US20070238751A1 (en) | 2004-04-07 | 2007-10-11 | Laine Dramane I | Muscarinic Acetylcholine Receptor Antagonists |
PE20060259A1 (es) | 2004-04-27 | 2006-03-25 | Glaxo Group Ltd | Compuestos de quinuclidina como antagonistas del receptor de acetilcolina muscarinico |
JP2007537261A (ja) | 2004-05-13 | 2007-12-20 | グラクソ グループ リミテッド | ムスカリン性アセチルコリン受容体アンタゴニスト |
WO2005118594A1 (en) | 2004-05-28 | 2005-12-15 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
WO2006005057A2 (en) | 2004-06-30 | 2006-01-12 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
JP2008509159A (ja) | 2004-08-05 | 2008-03-27 | グラクソ グループ リミテッド | ムスカリン性アセチルコリン受容体拮抗薬 |
WO2006017767A2 (en) | 2004-08-06 | 2006-02-16 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
US20090258858A1 (en) | 2004-10-29 | 2009-10-15 | Jakob Busch-Petersen | Muscarinic acetylcholine receptor antagonists |
WO2006055553A2 (en) * | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
WO2006055503A2 (en) | 2004-11-15 | 2006-05-26 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
PE20061162A1 (es) | 2004-12-06 | 2006-10-14 | Smithkline Beecham Corp | Compuestos derivados olefinicos de 8-azoniabiciclo[3.2.1]octanos |
PE20060826A1 (es) | 2004-12-06 | 2006-10-08 | Smithkline Beecham Corp | Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende |
WO2006065788A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Novel muscarinic acetylcholine receptor antagonists |
WO2006065755A2 (en) | 2004-12-13 | 2006-06-22 | Glaxo Group Limited | Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists |
WO2007018514A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
WO2007018508A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetycholine receptor antagonists |
US20080275079A1 (en) | 2005-08-02 | 2008-11-06 | Glaxo Group Limited | M3 Muscarinic Acetylcholine Receptor Antagonists |
US20080234315A1 (en) | 2005-08-02 | 2008-09-25 | Jakob Busch-Petersen | M3 Muscarinic Acetylcholine Receptor Antagonists |
WO2007022351A2 (en) | 2005-08-18 | 2007-02-22 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
WO2007123953A2 (en) * | 2006-04-19 | 2007-11-01 | Memory Pharmaceuticals Corporation | Phosphodiesterase 4 inhibitors |
GB0614570D0 (en) * | 2006-07-21 | 2006-08-30 | Glaxo Group Ltd | Compounds |
-
2009
- 2009-02-04 TW TW098103478A patent/TW201000476A/zh unknown
- 2009-02-04 CL CL2009000250A patent/CL2009000250A1/es unknown
- 2009-02-04 PE PE2009000167A patent/PE20091552A1/es not_active Application Discontinuation
- 2009-02-04 AR ARP090100367A patent/AR070562A1/es not_active Application Discontinuation
- 2009-02-04 UY UY31637A patent/UY31637A1/es not_active Application Discontinuation
- 2009-02-05 CA CA2714352A patent/CA2714352A1/en not_active Abandoned
- 2009-02-05 BR BRPI0908008-2A patent/BRPI0908008A2/pt not_active IP Right Cessation
- 2009-02-05 KR KR1020107019677A patent/KR20100113155A/ko not_active Application Discontinuation
- 2009-02-05 WO PCT/US2009/033128 patent/WO2009100166A1/en active Application Filing
- 2009-02-05 AU AU2009212408A patent/AU2009212408A1/en not_active Abandoned
- 2009-02-05 JP JP2010545972A patent/JP2011511082A/ja active Pending
- 2009-02-05 US US12/365,930 patent/US8084449B2/en not_active Expired - Fee Related
- 2009-02-05 MX MX2010008690A patent/MX2010008690A/es not_active Application Discontinuation
- 2009-02-05 EP EP09708282A patent/EP2259681A4/en not_active Withdrawn
- 2009-02-05 EA EA201070916A patent/EA201070916A1/ru unknown
- 2009-02-05 CN CN2009801123576A patent/CN101990401A/zh active Pending
-
2010
- 2010-07-30 DO DO2010000235A patent/DOP2010000235A/es unknown
- 2010-08-02 IL IL207352A patent/IL207352A0/en unknown
- 2010-09-01 CR CR11665A patent/CR11665A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UY31637A1 (es) | 2009-08-03 |
JP2011511082A (ja) | 2011-04-07 |
CL2009000250A1 (es) | 2009-09-11 |
TW201000476A (en) | 2010-01-01 |
AR070562A1 (es) | 2010-04-21 |
IL207352A0 (en) | 2010-12-30 |
CN101990401A (zh) | 2011-03-23 |
US8084449B2 (en) | 2011-12-27 |
MX2010008690A (es) | 2010-08-30 |
EP2259681A4 (en) | 2012-04-04 |
CA2714352A1 (en) | 2009-08-13 |
DOP2010000235A (es) | 2011-01-15 |
BRPI0908008A2 (pt) | 2015-08-18 |
PE20091552A1 (es) | 2009-10-25 |
AU2009212408A1 (en) | 2009-08-13 |
KR20100113155A (ko) | 2010-10-20 |
EA201070916A1 (ru) | 2011-02-28 |
EP2259681A1 (en) | 2010-12-15 |
WO2009100166A1 (en) | 2009-08-13 |
US20090203657A1 (en) | 2009-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2011000218A (es) | Derivados de sulfonamida | |
CR11665A (es) | Farmacoforos duales-antagonistas muscarinicos de pde4 | |
GT201200307A (es) | NUEVOS DERIVADOS DE CICLOHEXILAMINA QUE TIENEN ACTIVIDAD COMO AGONISTAS ADRENÉRGICOS ß2 Y COMO ANTAGONISTAS MUSCARÍNICOS M3 | |
HN2011001593A (es) | Piridiloxi-indoles del vegf-r2 y uso de los mismos para el tratmiento de enfermedades | |
CR10356A (es) | Derivados de 4-benzilphthalazinona 2-sustituidos como antagonistas de histamina h1 y h3 | |
ECSP11011526A (es) | Aril-piridinas como inhibidoras de sintasa de aldosterona | |
CR20140032A (es) | Compuestos de tetrahidropirido-piridina y tetrahidropirido-pirimidina y su uso como modulares de receptores de c5a | |
UY31922A (es) | Compuestos | |
BR112015015468A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método | |
ECSP088904A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
CO6640327A2 (es) | Compuestos de pirazol como inhibidores del receptor sigma | |
UY30572A1 (es) | N-(1-ftalazin-1-il-piperidin-4-il)-amidas como moduladores del receptor ep2 | |
CR20110269A (es) | Lactamas como inhibidores de beta secretasa | |
UY33277A (es) | Compuestos de anillo espiro-tetraciclico como moduladores de beta-secretasa y métodos de uso | |
UY33655A (es) | Co-cristales y sales de inhibidores de ccr30 | |
UY33530A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias | |
CR20150322A (es) | Nuevos derivados carbamato de ciclohexilo y quinuclidinilo que tienen actividad como agonistas b2 adrenérgicos y como antagonistas muscarínicos m3 | |
UY33348A (es) | Compuestos de furopiridina y usos de los mismos | |
ECSP13012838A (es) | Nuevos compuestos de benzodioxol-piperazina | |
AR059864A1 (es) | Compuesto de benzamida composicion farmaceutica que lo comprende su uso para preparar un medicamento y procedimientos para su preparacion | |
UY33529A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias? | |
CO6290762A2 (es) | Nuevos derivados quinazolin-2, 4-diona y una composicion farmaceutica para prevenir a tratar la enfermedad neurocerebral | |
PA8795901A1 (es) | Compuestos novedosos activos como antagonistas de receptores muscarinicos | |
BR112013012719A2 (pt) | "compostos como moduladores de receptor com utilidade terapêutica". | |
DOP2007000120A (es) | Derivados de imminoimidazopiridina que tienen actividad antitrombotica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |